Back to Search Start Over

Implementation Study of Professional Pharmacy Services in Community Pharmacies

Authors :
De Vriese, Carine
Bugnon, Olivier
Amighi, Karim
Schneider, Marie Paule M.P.
Langer, Ingrid
Pochet, Stéphanie
Malonne, Hugues
Hamdani, Jamila
Bernard, Vrijens
Dalleur, Olivia
Lelubre, Melanie
De Vriese, Carine
Bugnon, Olivier
Amighi, Karim
Schneider, Marie Paule M.P.
Langer, Ingrid
Pochet, Stéphanie
Malonne, Hugues
Hamdani, Jamila
Bernard, Vrijens
Dalleur, Olivia
Lelubre, Melanie
Publication Year :
2018

Abstract

Introduction: In recent year, the role of the pharmacist has evolved from product-focused to patient-focused activities. Following this evolution, new professional pharmacy services were simultaneously developed by researchers and started to be legally implemented and remunerated for community pharmacists around the world. Implementation, essential to ensure a good programme delivery and therefore its effectiveness, was seen as a passive process for which diffusion and dissemination were sufficient to translate research into practice. However, the transition from theory to practice is often difficult as different factors hinder or facilitate the implementation of such services. In consequence of that, implementation research started to be developed in the community pharmacy field to understand and fil the gap between theory and practice.Objectives of the thesis: Three projects were conducted in Belgium and Switzerland; (1) to understand the implementation of an existing programme in Belgium; the isotretinoin pregnancy prevention programme (PPP) (Chapter IV, point 4.1), and (2) to study the implementation of two new developed pharmaceutical services, which include an interview between the pharmacist and the patient and require interprofessional collaboration; the medication adherence program in Switzerland and the medication review in Belgium (Chapter IV, point 4.2). Methods: To understand the implementation of the isotretinoin PPP, two studies were conducted. The first study was a survey sent to health care professionals (pharmacists, general practitioners and dermatologists) and patients. The outcomes of the survey were the PPP awareness and compliance to safety recommendations related to the teratogenic risk of isotretinoin. The second study was cross-sectional and analysed the reimbursed prescription data of the Belgian population taking isotretinoin between January 2012 and August 2015. The outcomes were medication adherence to isotretinoin and to contraception<br />Doctorat en Sciences biomédicales et pharmaceutiques (Pharmacie)<br />info:eu-repo/semantics/nonPublished

Details

Database :
OAIster
Notes :
217 p., 3 full-text file(s): application/pdf | application/pdf | application/pdf, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1039721948
Document Type :
Electronic Resource